---
layout: page
---

# 邱敏实验室 
<div>
<img src="/images/teams/group1.jpg" class="floatpic" width="1500" height="800">
</div>>
欢迎访问 **邱敏实验室**.

我们致力于开发基于核酸的治疗方法，并通过合成脂质纳米粒子来实现这一目标。我们的研究团队由充满热情和创新精神的科学家组成，专注于探索前沿生物技术，推动医学进步。无论是RNA疫苗、基因治疗还是其他核酸药物，我们都在不断努力，为改善人类健康做出贡献。欢迎访问我们的实验室主页，了解更多关于我们最新研究进展和成果的信息。

---

## 重点成果
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Image Gallery with Titles and Descriptions</title>
    <style>
        .image-container {
            display: flex;
            flex-direction: row;
            justify-content: center;
            align-items: flex-start;
            margin: 20px;
        }
        .image {
            width: 200px; /* Adjust image width as needed */
            height: auto;
            margin: 10px;
            border: 1px solid #ccc;
        }
        .image-info {
            text-align: center;
        }
        .image-title {
            font-weight: bold;
            margin-bottom: 3px;
        }
        .image-description {
            font-size: 0.9em;
        }
    </style>
</head>
<body>
    <div class="image-container">
        <div class="image">
            <img src="images/article/article1.jpg" alt="article1">
            <div class="image-info">
                <h5 class="image-title"><a href="https://www.pnas.org/doi/10.1073/pnas.2116271119">Lung-selective mRNA delivery of synthetic lipid nanoparticles for the treatment of pulmonary lymphangioleiomyomatosis</a> </h5>
            </div>
        </div>
        <div class="image">
            <img src="images/article/article2.jpg" alt="Image 2 Description">
            <div class="image-info">
                <h5 class="image-title"><a href="https://www.pnas.org/doi/full/10.1073/pnas.2020401118">Lipid nanoparticle-mediated codelivery of Cas9 mRNA and single-guide RNA achieves liver-specific in vivo genome editing of Angptl3</a> </h5>
            </div>
        </div>
        <div class="image">
            <img src="images/article/article3.jpg" alt="Image 3 Description">
            <div class="image-info">
                <h5 class="image-title"><a href="https://pubs.acs.org/doi/10.1021/acs.accounts.1c00500">Developing Biodegradable Lipid Nanoparticles for Intracellular mRNA Delivery and Genome Editing</a> </h5>
            </div>
        </div>
    </div>
</body>



[//]: # (- Qiu, M.#; Tang, Y.#,*, Chen, J. #; Muriph, R.; Ye, Z.; Huang, C.; Evans, J.; Henske, E.*; Xu, Q.*, Lung-selected mRNA delivery of synthetic lipid nanoparticles for the treatment of pulmonary lymphangioleiomyomatosis. Proc. Natl. Acad. Sci. U. S. A. 2022, 119, e2116271119. ESI Highly Cited Paper.)

[//]: # (- Qiu, M.#; Glass, Z.#; Chen, J.; Haas, M.; Jin, X.; Zhao, X.; Rui, X.; Ye, Z.; Li, Y.; Zhang, F; Xu, Q.*, Lipid nanoparticle-mediated codelivery of Cas9 mRNA and single guide RNA achieves liver-specific in vivo genome editing of Angptl3. Proc. Natl. Acad. Sci. U. S. A. 2021, 118, e2020401118. ESI Highly Cited Paper. )
[//]: # (## 最新动态)

[//]: # ()
[//]: # (- **05-2024：**xxx论文发表 🎉)

[//]: # ()

[//]: # (- **April 2024：**Our work *BLEGuard* has been accepted to [MobiSys 2024]&#40;https://www.sigmobile.org/mobisys/2024/&#41; as a poster paper. See you in Japan!)

[//]: # (- **March 2024：**Very excited to get a MPhil offer from Engineering department at Cambridge University!)

[//]: # (- **Dec 2023：**Very excited to be selected as [AAAI-24 UC Scholar]&#40;https://aaai.org/aaai-conference/undergraduate-consortium-program/&#41;. See you in Canada!)

[//]: # (- **Dec 2023：**Got a MSc offer from the physics department of Imperial College London.)

[//]: # (- **Aug 2023：**Happy to be awarded the FEPG Scholarship.)

[//]: # (- **May 2023：**Happy to be awarded the XiamenAir Scholarship.)

[//]: # (- **May 2023：**Collected the Finalist Award in MCM 2023 &#40;Top 1%&#41;.)

[//]: # (- **Jun 2022：**Started research programme at [Cambridge AI Group]&#40;https://www.cl.cam.ac.uk/research/ai/&#41;, advised by Prof. Pietro Liò.)

[//]: # (<blockquote class="twitter-tweet"><p lang="en" dir="ltr">Thrilled to be an AAAI-UC Scholar at <a href="https://twitter.com/hashtag/AAAI24?src=hash&amp;ref_src=twsrc%5Etfw">#AAAI24</a>, thanks to <a href="https://twitter.com/hashtag/AAAI?src=hash&amp;ref_src=twsrc%5Etfw">#AAAI</a> &amp; <a href="https://twitter.com/hashtag/GoogleExploreCSR?src=hash&amp;ref_src=twsrc%5Etfw">#GoogleExploreCSR</a> for the sponsorship. Grateful for the knowledge gained and new friendships formed.<br><br>Wonderful trip in Vancouver. Looking forward to staying connected with all.<a href="https://twitter.com/hashtag/AAAI24?src=hash&amp;ref_src=twsrc%5Etfw">#AAAI24</a> <a href="https://twitter.com/hashtag/Vancouver?src=hash&amp;ref_src=twsrc%5Etfw">#Vancouver</a> <a href="https://twitter.com/hashtag/GoogleExploreCSR?src=hash&amp;ref_src=twsrc%5Etfw">#GoogleExploreCSR</a> <a href="https://t.co/wUQUp8XlSM">pic.twitter.com/wUQUp8XlSM</a></p>&mdash; Hanlin CAI &#40;seeking a PhD position 2025&#41; &#40;@lancecai2002&#41; <a href="https://twitter.com/lancecai2002/status/1762210025173344260?ref_src=twsrc%5Etfw">February 26, 2024</a></blockquote> <script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>)

